16 Feb 2022 14:38

Russian Health Ministry permits Gamaleya Center to conduct clinical trials of Covid-19 VLP vaccine - register

MOSCOW. Feb 16 (Interfax) - The Gamaleya Center has received permission from the Russian Health Ministry to conduct clinical trials of its coronavirus vaccine based on virus-like particles (VLPs), according to the state register of permitted clinical trials.

The clinical trials, which will involve 600 volunteers, are due to start on February 16, 2022, and will run until December 30, 2022, it said.